Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 3,800.00
+20.00 (0.53%)
Last updated: Nov 5, 2025, 2:20 PM KST
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 372.95 billion as of November 4, 2025. Its market cap has increased by 8.31% in one year.
Market Cap
372.95B
Enterprise Value
314.04B
Revenue
179.16B
Ranking
n/a
PE Ratio
31.10
Stock Price
3,800.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 372.95B, an increase of 484.97%. That is a compound annual growth rate of 6.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 372.95B | 18.70% |
| Dec 30, 2024 | 314.21B | -24.75% |
| Dec 28, 2023 | 417.57B | -30.29% |
| Dec 29, 2022 | 598.98B | -32.17% |
| Dec 30, 2021 | 883.07B | -54.11% |
| Dec 30, 2020 | 1.92T | 109.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |